Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study in Retinal Transplantation for Retinitis Pigmentosa.

This study has been completed.
Sponsor:
Collaborator:
Foundation Fighting Blindness Clinical Research Institute
Information provided by (Responsible Party):
Radtke, Norman D., M.D.
ClinicalTrials.gov Identifier:
NCT00345917
First received: June 28, 2006
Last updated: April 10, 2012
Last verified: April 2012